Corteva (NYSE:CTVA) Reaches New 12-Month High - What's Next?
π Corteva stock hit a new 52-week high of $87.89 with strong trading volume on Friday.
π Goldman Sachs raised its price target to $96.00 and Morgan Stanley increased theirs to $95.00 following recent reports.
π° The company reported Q1 earnings of $1.50 per share, beating analyst estimates by $0.32.
π Revenue for the quarter reached $4.91 billion, an 11% increase compared to the previous year.
π Corteva achieved a net margin of 6.50% and a return on equity of 9.95% in the latest quarter.
πΈ A quarterly dividend of $0.18 was paid, offering an annualized yield of 0.8% to shareholders.
π¦ Institutional ownership stands at 81.54%, with major funds like Avior Wealth Management increasing stakes significantly.
π± Corteva focuses on seed genetics, crop protection chemistries, and digital tools for farmers.
π Analysts project full-year 2026 earnings per share to be around $3.72.
- Corteva shares reached a new 52-week high of $87.89, indicating strong market momentum and investor interest.
- The company beat quarterly earnings estimates by $0.32 per share, reporting $1.50 EPS against a consensus of $1.18.
- Revenue grew 11% year-over-year to $4.91 billion, exceeding analyst expectations of $4.64 billion.
- Major investment banks including Goldman Sachs and Morgan Stanley have raised price targets and issued buy ratings.
- The business maintains a healthy net margin of 6.50% and a return on equity of 9.95%.
- Institutional investors are accumulating shares, with Avior Wealth Management increasing its position by 464.7% in the fourth quarter.
- Corteva offers a consistent dividend yield of 0.8% with a sustainable payout ratio of 42.35%.